Olema Oncology
0 followers
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor... Read more
Org chart
Sean P. Bohen
President & CEO
Sean P. Bohen
Collapse
Naseem Zojwalla
Chief Medical Officer
Shane Kovacs
Chief Operating & Financial Officer
David C. Myles
Chief Development Officer
Sasha Austin
VP, Finance & Controller
Julie Dexter
VP & Head of People
Kristin Lanzi
VP, Information Technology
Jim Zhang
VP, CMC
Kamesh Kuchimanchi
VP, Regulatory Affairs & Quality Assurance
Geoffrey Mogilner
VP, Investor Relations & Communications
Peter Kushner
Chief Scientific Officer
Kristin Lowland Lanzi
VP Of IT At Olema Oncology
